Grant: Discovery Grants Program - Individual
Carleton University
$35,500.00
The effects of diabetes and stressors on markers of neurodegeneration in the mouse brain
FY 2006-07
Summary
Exposure to stressors results in a series of biological responses to allow individuals to deal effectively with danger. However, following long-term exposure to stressors these responses can become maladaptive, leading to neuronal damage (neurodegeneration), defects in cognitive processes, and to diseases such as depression and diabetes. Similarly, neurodegeneration and cognitive decline are associated with diabetes in both humans and animal models of the disease. This proposal seeks to use mouse models of both early-onset and late-onset diabetes, combined with exposure to stressful environments, to investigate cognitive defects and neurodegeneration in the mammalian brain. We will address two specific questions. 1) Are the cognitive changes associated with stress and diabetes more severe when stressors and diabetes are combined? 2) What neurodegenerative symptoms are associated with diabetes, and do stressors exacerbate these symptoms? Cognition will be investigated using a series of behavioural approaches to assess learning and memory, plus several tests to assess anxiety-like behaviour in mice. These analyses will be complemented by the following studies analyzing symptoms of neurodegeneration in the brain. 1) The hippocampus is a brain region involved in learning and memory, and is one of only two brain regions in which large numbers of new neurons continue to be generated into adulthood. We will investigate whether stress and diabetes result in changes in the rate at which these new neurons are formed. 2) Cytokines are protein molecules involved in the immune response, and some cytokines are altered in both diabetes and depression. We will analyze cytokine levels in the blood and brain of diabetic mice subject to stressors to determine whether these molecules contribute to neurodegenerative changes in the brain. 3) Finally, we will use state-of-the-art molecular genetics approaches to analyze changes in the activity of members of the fibroblast growth factor gene family following diabetes onset. This research will create a framework for the training of many students in techniques of animal behaviour, anatomy, and molecular biology.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
312465-2006
Name nom
Stead, John
Department département
Psychology
Organization id
23
Institution établissement
Carleton University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2006
Competition year année de concours
2006
Award amount
35500
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1011
Committee name en
Integrative Animal Biology
Committee name fr
Biologie Animale Intégrative
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
6308
Research subject group en
Psychology
Research subject group fr
Psychologie
Research subject en
Behavioural neuroscience
Research subject fr
Neurologie du comportement
Partie
1
Nb partie
5
Application title
The effects of diabetes and stressors on markers of neurodegeneration in the mouse brain
Keyword
NA
Application summary
Exposure to stressors results in a series of biological responses to allow individuals to deal effectively with danger. However, following long-term exposure to stressors these responses can become maladaptive, leading to neuronal damage (neurodegeneration), defects in cognitive processes, and to diseases such as depression and diabetes. Similarly, neurodegeneration and cognitive decline are associated with diabetes in both humans and animal models of the disease. This proposal seeks to use mouse models of both early-onset and late-onset diabetes, combined with exposure to stressful environments, to investigate cognitive defects and neurodegeneration in the mammalian brain. We will address two specific questions. 1) Are the cognitive changes associated with stress and diabetes more severe when stressors and diabetes are combined? 2) What neurodegenerative symptoms are associated with diabetes, and do stressors exacerbate these symptoms? Cognition will be investigated using a series of behavioural approaches to assess learning and memory, plus several tests to assess anxiety-like behaviour in mice. These analyses will be complemented by the following studies analyzing symptoms of neurodegeneration in the brain. 1) The hippocampus is a brain region involved in learning and memory, and is one of only two brain regions in which large numbers of new neurons continue to be generated into adulthood. We will investigate whether stress and diabetes result in changes in the rate at which these new neurons are formed. 2) Cytokines are protein molecules involved in the immune response, and some cytokines are altered in both diabetes and depression. We will analyze cytokine levels in the blood and brain of diabetic mice subject to stressors to determine whether these molecules contribute to neurodegenerative changes in the brain. 3) Finally, we will use state-of-the-art molecular genetics approaches to analyze changes in the activity of members of the fibroblast growth factor gene family following diabetes onset. This research will create a framework for the training of many students in techniques of animal behaviour, anatomy, and molecular biology.